HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of HDACs in optic nerve damage-induced nuclear atrophy of retinal ganglion cells.

Abstract
Optic neuropathies are characterized by retinal ganglion cell (RGC) death, resulting in the loss of vision. In glaucoma, the most common optic neuropathy, RGC death is initiated by axonal damage, and can be modeled by inducing acute axonal trauma through procedures such as optic nerve crush (ONC) or optic nerve axotomy. One of the early events of RGC death is nuclear atrophy, and is comprised of RGC-specific gene silencing, histone deacetylation, heterochromatin formation, and nuclear shrinkage. These early events appear to be principally regulated by epigenetic mechanisms involving histone deacetylation. Class I histone deacetylases HDACs 1, 2, and 3 are known to play important roles in the process of early nuclear atrophy in RGCs, and studies using both inhibitors and genetic ablation of Hdacs also reveal a critical role in the cell death process. Select inhibitors, such as those being developed for cancer therapy, may also provide a viable secondary treatment option for optic neuropathies.
AuthorsHeather M Schmitt, Cassandra L Schlamp, Robert W Nickells
JournalNeuroscience letters (Neurosci Lett) Vol. 625 Pg. 11-5 (06 20 2016) ISSN: 1872-7972 [Electronic] Ireland
PMID26733303 (Publication Type: Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Histone Deacetylase Inhibitors
  • Histone Deacetylases
Topics
  • Animals
  • Apoptosis
  • Atrophy
  • Disease Models, Animal
  • Epigenesis, Genetic
  • Glaucoma (metabolism, pathology, prevention & control)
  • Histone Deacetylase Inhibitors (therapeutic use)
  • Histone Deacetylases (metabolism)
  • Humans
  • Nerve Crush
  • Optic Nerve Diseases (enzymology, pathology, prevention & control)
  • Retinal Ganglion Cells (enzymology, pathology)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: